What My Patients Taught Me About LoveSEKERES, Mikkael A.Journal of clinical oncology. 2009, Vol 27, Num 28, pp 4817-4818, issn 0732-183X, 2 p.Article

Combination strategies in myelodysplastic syndromesORNSTEIN, Moshe C; SEKERES, Mikkael A.International journal of hematology. 2012, Vol 95, Num 1, pp 26-33, issn 0925-5710, 8 p.Article

Defining prior therapy in myelodysplastic syndromes and criteria for relapsed and refractory disease: implications for clinical trial design and enrollmentSEKERES, Mikkael A; STEENSMA, David P.Blood. 2009, Vol 114, Num 13, pp 2575-2580, issn 0006-4971, 6 p.Article

Blood consult: treating del(5q) myelodysplastic syndromesMUKHERJEE, Sudipto; TIU, Ramon V; SEKERES, Mikkael A et al.Blood. 2012, Vol 119, Num 2, pp 342-344, issn 0006-4971, 3 p.Article

The Epidemiology of Myelodysplastic SyndromesSEKERES, Mikkael A.Hematology/oncology clinics of North America. 2010, Vol 24, Num 2, issn 0889-8588, vii, 287-294 [9 p.]Article

Thalidomide Use and Digital GangreneKANG, Tyler Y; LOWE, Christopher J; SEKERES, Mikkael A et al.Journal of clinical oncology. 2006, Vol 24, Num 33, pp 5328-5328, issn 0732-183X, 1 p.Article

De Novo polycythaemia vera arising 5 years following acute myeloid leukemia remission: suggestion of a chemotherapy resistant JAK2 clonePORTELL, Craig A; SEKERES, Mikkael A; ROGERS, Heesun J et al.British journal of haematology. 2012, Vol 157, Num 2, pp 266-267, issn 0007-1048, 2 p.Article

Azacitidine : In myelodysplastic syndromes. CommentarySIDDIQUI, M. Asif A; SCOTT, Lesley J; SANTINI, Valeria et al.Drugs (Basel). 2005, Vol 65, Num 13, pp 1781-1791, issn 0012-6667, 11 p.Article

The incidence and impact of thrombocytopenia in myelodysplastic syndromesKANTARJIAN, Hagop; GILES, Francis; LIST, Alan et al.Cancer. 2007, Vol 109, Num 9, pp 1705-1714, issn 0008-543X, 10 p.Article

Refractory anemia with ringed sideroblasts associated with marked thrombocytosis (RARS-T), another myeloproliferative condition characterized by JAK2 V617F mutationSZPURKA, Hadrian; TIU, Ramon; MURUGESAN, Gurunathan et al.Blood. 2006, Vol 108, Num 7, pp 2173-2181, issn 0006-4971, 9 p.Article

The impact of a physician awareness group and the first year of training on hematology-oncology fellowsSEKERES, Mikkael A; CHERNOFF, Miriam; LYNCH, Thomas J et al.Journal of clinical oncology. 2003, Vol 21, Num 19, pp 3676-3682, issn 0732-183X, 7 p.Article

Development and validation of a model to predict platelet response to romiplostim in patients with lower-risk myelodysplastic syndromesSEKERES, Mikkael A; GIAGOUNIDIS, Aristoteles; KANTARJIAN, Hagop et al.British journal of haematology. 2014, Vol 167, Num 3, pp 337-345, issn 0007-1048, 9 p.Article

Impact of remission induction chemotherapy on survival in older adults with acute myeloid leukemiaBAZ, Rachid; RODRIGUEZ, Cristina; FU, Alex Z et al.Cancer. 2007, Vol 110, Num 8, pp 1752-1759, issn 0008-543X, 8 p.Article

Hemochromatosis-associated gene mutations in patients with myelodysplastic syndromes with refractory anemia with ringed sideroblastsNEARMAN, Zachary P; SZPURKA, Hadrian; SERIO, Bianca et al.American journal of hematology. 2007, Vol 82, Num 12, pp 1076-1079, issn 0361-8609, 4 p.Article

Demonstration of additional benefit in adding lenalidomide to azacitidine in patients with higher-risk myelodysplastic syndromesSEKERES, Mikkael A; O'KEEFE, Christine; LIST, Alan F et al.American journal of hematology. 2011, Vol 86, Num 1, pp 102-103, issn 0361-8609, 2 p.Article

Phase 2, single-arm trial to evaluate the effectiveness of darbepoetin alfa for correcting anaemia in patients with myelodysplastic syndromesGABRILOVE, Janice; PAQUETTE, Ronald; LYONS, Roger M et al.British journal of haematology. 2008, Vol 142, Num 3, pp 379-393, issn 0007-1048, 15 p.Article

Characteristics of US Patients with Myelodysplastic Syndromes : Results of Six Cross-sectional Physician SurveysSEKERES, Mikkael A; SCHOONEN, W. Marieke; KANTARJIAN, Hagop et al.Journal of the National Cancer Institute. 2008, Vol 100, Num 21, pp 1542-1551, issn 0027-8874, 10 p.Article

A decision analysis to determine the appropriate treatment for low-risk myelodysplastic syndromesSEKERES, Mikkael A; FU, Alex Z; MACIEJEWSKI, Jaroslaw P et al.Cancer. 2007, Vol 109, Num 6, pp 1125-1132, issn 0008-543X, 8 p.Article

Relationship of Treatment-Related Cytopenias and Response to Lenalidomide in Patients With Lower-Risk Myelodysplastic SyndromesSEKERES, Mikkael A; MACIEJEWSKI, Jaroslaw P; GIAGOUNIDIS, Aristotle A. N et al.Journal of clinical oncology. 2008, Vol 26, Num 36, pp 5943-5949, issn 0732-183X, 7 p.Article

Daptomycin-resistant Enterococcus faecium in a patient with acute myeloid leukemiaLONG, Jennifer K; CHOUEIRI, Toni K; HALL, Geraldine S et al.Mayo Clinic proceedings. 2005, Vol 80, Num 9, pp 1215-1216, issn 0025-6196, 2 p.Article

Results of a Randomized, Double-Blind Study of Romiplostim Versus Placebo in Patients With Low/Intermediate-1-Risk Myelodysplastic Syndrome and ThrombocytopeniaGIAGOUNIDIS, Aristoteles; MUFTI, Ghulam J; WOODARD, Paul et al.Cancer. 2014, Vol 120, Num 12, pp 1838-1846, issn 0008-543X, 9 p.Article

Topography, Clinical, and Genomic Correlates of 5q Myeloid Malignancies RevisitedJEREZ, Andres; GONDEK, Lukasz P; MCDEVITT, Michael A et al.Journal of clinical oncology. 2012, Vol 30, Num 12, pp 1343-1349, issn 0732-183X, 7 p.Article

Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3AJANKOWSKA, Anna M; MAKISHIMA, Hideki; HSI, Eric D et al.Blood. 2011, Vol 118, Num 14, pp 3932-3941, issn 0006-4971, 10 p.Article

Single Cycle of Arsenic Trioxide-Based Consolidation Chemotherapy Spares Anthracycline Exposure in the Primary Management of Acute Promyelocytic LeukemiaGORE, Steven D; GOJO, Ivana; SCHACHTER-TOKARZ, Esther et al.Journal of clinical oncology. 2010, Vol 28, Num 6, pp 1047-1053, issn 0732-183X, 7 p.Article

Risk for Developing Myelodysplastic Syndromes in Prostate Cancer Patients Definitively Treated With RadiationMUKHERJEE, Sudipto; REDDY, Chandana A; MACIEJEWSKI, Jaroslaw P et al.Journal of the National Cancer Institute. 2014, Vol 106, Num 3, issn 0027-8874, 1.1-1.12Article